UnitedHealth Group Incorporated (UNH)
NYSE: UNH · Real-Time Price · USD
309.11
+6.49 (2.14%)
At close: Jun 27, 2025, 4:00 PM
308.38
-0.73 (-0.24%)
After-hours: Jun 27, 2025, 7:59 PM EDT
UnitedHealth Group Revenue
UnitedHealth Group had revenue of $109.58B in the quarter ending March 31, 2025, with 9.80% growth. This brings the company's revenue in the last twelve months to $410.06B, up 8.06% year-over-year. In the year 2024, UnitedHealth Group had annual revenue of $400.28B with 7.71% growth.
Revenue (ttm)
$410.06B
Revenue Growth
+8.06%
P/S Ratio
0.69
Revenue / Employee
$1,025,143
Employees
400,000
Market Cap
280.41B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 400.28B | 28.66B | 7.71% |
Dec 31, 2023 | 371.62B | 47.46B | 14.64% |
Dec 31, 2022 | 324.16B | 36.57B | 12.71% |
Dec 31, 2021 | 287.60B | 30.46B | 11.84% |
Dec 31, 2020 | 257.14B | 14.99B | 6.19% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
Thermo Fisher Scientific | 42.90B |
UNH News
- 1 day ago - UnitedHealth appoints new CEO to run health services division - Reuters
- 1 day ago - UnitedHealth Group Incorporated Investor Alert (NYSE: UNH): Schubert Jonckheer & Kolbe LLP Investigating Potential Shareholder Claims Against the Company's Officers and Directors Following DOJ Probe and for Possible False Statements - PRNewsWire
- 2 days ago - Why The Market Is Wrong About UnitedHealth Group - Seeking Alpha
- 2 days ago - UnitedHealth: At Rock Bottom The Only Way Is Up - Seeking Alpha
- 3 days ago - Buying A Dollar For 60 Cents: 2 Dividend Gems I'd Bet The House On - Seeking Alpha
- 4 days ago - AM Best Assigns Issue Credit Ratings to UnitedHealth Group Incorporated's New Senior Unsecured Notes - Business Wire
- 4 days ago - UnitedHealth Group Recommends Shareholders Reject "Mini-Tender" Offer by Tutanota - Business Wire
- 4 days ago - US health chief Kennedy met with insurers on prior authorization requirements - Reuters